Progestogen for treating threatened miscarriage Edited (no change to conclusions)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Progestogen for Treating Threatened Miscarriage Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435420/all/Efavirenz_or_nevirapine_in_three‐drug_combination_therapy_with_two_nucleoside_or_nucleotide‐reverse_transcriptase_inhibitors_for_initial_treatment_of_HIV_infection_in_antiretroviral‐naïve_individuals_Unchanged. Accessed 07 June 2023.
Progestogen for treating threatened miscarriage Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435420/all/Efavirenz_or_nevirapine_in_three‐drug_combination_therapy_with_two_nucleoside_or_nucleotide‐reverse_transcriptase_inhibitors_for_initial_treatment_of_HIV_infection_in_antiretroviral‐naïve_individuals_Unchanged. Accessed June 7, 2023.
Progestogen for treating threatened miscarriage Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435420/all/Efavirenz_or_nevirapine_in_three‐drug_combination_therapy_with_two_nucleoside_or_nucleotide‐reverse_transcriptase_inhibitors_for_initial_treatment_of_HIV_infection_in_antiretroviral‐naïve_individuals_Unchanged
Progestogen for Treating Threatened Miscarriage Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 June 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435420/all/Efavirenz_or_nevirapine_in_three‐drug_combination_therapy_with_two_nucleoside_or_nucleotide‐reverse_transcriptase_inhibitors_for_initial_treatment_of_HIV_infection_in_antiretroviral‐naïve_individuals_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Progestogen for treating threatened miscarriage Edited (no change to conclusions)
ID - 435420
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435420/all/Efavirenz_or_nevirapine_in_three‐drug_combination_therapy_with_two_nucleoside_or_nucleotide‐reverse_transcriptase_inhibitors_for_initial_treatment_of_HIV_infection_in_antiretroviral‐naïve_individuals_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -